Related references
Note: Only part of the references are listed.The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong
Joseph T. Wu et al.
CLINICAL INFECTIOUS DISEASES (2010)
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/HINI 2009
P. Hardelid et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
Elizabeth Miller et al.
LANCET (2010)
Real-Time Epidemic Monitoring and Forecasting of H1N1-2009 Using Influenza-Like Illness from General Practice and Family Doctor Clinics in Singapore
Jimmy Boon Som Ong et al.
PLOS ONE (2010)
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
Claire S. Waddington et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine.
Tristan W. Clark et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Assessing the severity of the novel influenza A/H1N1 pandemic
Tini Garske et al.
BRITISH MEDICAL JOURNAL (2009)
Share Paper
